Prognostic factors for treatment failure of imiquimod treatment in basal cell carcinoma - an observational study

J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e475-e477. doi: 10.1111/jdv.17962. Epub 2022 Feb 8.

B J A Verkouteren^{1

2}, L C F Oostewechel¹, P J Nelemans³, K A E Sinx^{1

2}, A H M M Arits^{1

4}, A I P Vernemmen⁵, V J L Winnepenninckx⁵, N W J Kelleners-Smeets^{1

2}, K Mosterd^{1

2}

¹ Department of Dermatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
² GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
³ Department of Epidemiology, Maastricht University Medical Centre, Maastricht, The Netherlands.
⁴ Department of Dermatology, Catherina Hospital, Eindhoven, The Netherlands.
⁵ Department of Pathology, Maastricht University, Maastricht, The Netherlands.

No abstract available

Publication types